An interesting candidate gene for investigation of the impact of genetic variation on the risk of CMV infection is the nuclear transcription factor κB (NF-κB; nuclear factor kappa-light-chain enhancer of activated B cells). The gene discussed is NFKB1; the disease is cytomegalovirus infection.